Clinical Trial Update: Antiviral Clinical Trial for Long Covid-19 [Phase 2]

View source ↗

Summary

A Phase 2 antiviral trial for long COVID-19 is currently recruiting, sponsored by Icahn School of Medicine at Mount Sinai.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Long Covid | Phase 2 | Status: RECRUITING